Third-Quarter Filing: Good Things Take Time; Form-10,

New Post Public Reply Private Reply Replies (0) Message Board
speckulater
348
Third-Quarter Filing: Good Things Take Time; Form-10, S-1




eisibrush.png





BLOG-11/4 (With- Three -Updates): HHSE/MyFlix Key-Events Outline & Business Model


FYI
I have been informed there was a third Addition (not just two) made to the Original BLOG. All 3 Updates are highlighted in red below. Notify me of any errors.





kcobghhseblog.png



Sunday, November 4, 2018

HHSE / MYFLIX - Outline of Key Events & Business Model

Greetings HHSE Friends & Followers - Several different versions of BLOG POSTS have been created in the past two weeks - as requested by Shareholders and "longs" wanting updates on a wide variety of issues. But, the operational distractions from current product shipments - combined with some management uncertainty about the ongoing medical status of Fred Shefte - created enough of a demand for focus as to distract from such corporate communications and shareholder updates.

With Fred Shefte now back at the office full-time, the company is able to redirect attentions towards the current issues and long-term direction. So, what are the current issues and long term goals? We will outline these as briefly as possible - as the detailed answers would comprise more than 60-pages of disclosures for a Form 10 or S-1 filing.

IMMEDIATE ISSUES

HHSE continues to service those titles that were produced, acquired or otherwise released in some manner under what management is now calling "the old business model." These title are what many in the industry would characterize as lower-tier Independent Releases - despite most having some level of theatrical visibility prior to home video or digital release.

The current titles include this TUESDAY's release of "GETTING GRACE" - which enjoyed theatrical exposure on more than 95-theatres in 35 of the top 40 markets this past Spring. Next up are the December home video releases of "RIDE UNITED" (Redbull Media House) and "AMERICA UNITED" (ABC Television), followed by a January 1st home video release of "SLEEPER CELL: THE ALGERIAN" and a February release of "THE LENNON REPORT." Three additional titles that had some level of theatrical release will follow in March, April and May - and these collectively represent "the end" of the older business model for HHSE to handle films with limited theatrical releases. Due to contractual obligations made to these producers, HHSE will follow-thru on the home video marketing of each, despite the longer term goal of phasing out of such titles.


SIDE NOTE : DVDs of "GETTING GRACE" can be pre-ordered on-line now via AMAZON or WALMART, and we encourage shareholders to help us achieve a strong week-one sales through the purchase of a copy!

AMAZON.com listing (currently at # 198 Best Seller):

https://www.amazon.com/Getting-Grace-Daniel-R...+grace+dvd

WALMART.com listing (currently WM's # 38 BEST SELLER!
https://www.walmart.com/ip/Getting-Grace-DVD/358583120


OTHER IMMEDIATE ISSUES include jump-starting some LEGAL responses that were put onto hold during Shefte's 7-week absence from the office. Specific items include: Stay of enforcement and re-opening of cases for JSJ and Bedrock; Catch-Up on structured settlement payments with CD Video, GDC, and Ackerman; Countersuit against Crimson and pre-Form 10 settlements with other significant creditors (including Graham, Andersons and Southwinds).

HHSE / MYFLIX ONGOING BUSINESS MODEL? With management having determined that the lower-end titles are cash-intensive, time-consuming and deliver only a very marginal revenue upside, the goal has been to identify specific areas within the entertainment industry where a company such as Hannover House can excel. For this reason, the company determined that the best strategy for maximizing revenues and bottom line results is a two-pronged approach: Major Films for HHSE and MyFlix as a one-stop digital streaming store.

By "Major Films" we mean that the company plans to release FOUR (4) features per year that have high-profile casts and which deserve (and get) broad theatrical distribution (500 or more locations). The first of these "Major Films" is a feature that's 95% completed at this time, and which HHSE plans to release in early MARCH, 2019. This title has NOT yet been announced.


It is management's belief that MOST of the titles comprising these four annual tent-poles will ultimately need to be PRODUCED by (or with the assistance of), HHSE in the Studio capacity. This is because at the film festival circuit level - generally speaking - any film of commercial merit has either been pre-sold to the major studios or ends up sparking a bidding for for the acquisition of rights (and HHSE cannot realistically expect to compete against the current acquisitions funding of Amazon, Netflix or the Major Studio specialty divisions). To get these "Major Films" - HHSE is likely going to have to act as a catalyst to spark the production. A good example of how this might occur is listed below (see "MELTDOWN" .

With respect to MYFLIX - while the on-boarding of titles continues at full speed (now at 1,168 titles) -
FULLY WITH MASTERS, as opposed to 2,100 with "only Metadata" and not fully with conformed masters) - and acquisition of more studio supplier partners continues (now representing well in excess of 10,000 titles) - the actual consumer launch of the site does not look likely for the next few weeks. We are now going into the insane HOLIDAY season for ads and digital media, creating both a shortage of promotional inventories and a spike in costs. The cost for 30-second TV Ads on national cable (for instance), drops by more than 50% after January 1st... which also corresponds with terrific cold-weather, indoors-type seasonality (perfect for our MyFlix launch - and also corresponds with when we will surpass the 2,500 titles ON BOARDED level).

FINANCING FOR "MAJOR FILMS & MYFLIX" - Some shareholders have asked (rightfully so) how a company (that has been horribly cash-strapped from its stubborn focus on indie films for video release) anticipates financing this ambitious involvement in the "Major Films" as well as in the competitive world of launching a major MyFlix site?

Here's how:


1). FORM 10 REGISTRATION - The long-awaited filing of the company's registration statement is the first step in the company's overall new launch. Large funds and investors that have been hesitant (or prohibited) from supporting HHSE as a Pinksheet stock will now be able to invest in HHSE shares. Management anticipates that the act of filing the Form 10 could (and should) result in a PPS of $.03 or higher. The Form 10 may be filed in the next few weeks, and the impact to the HHSE share price might be seen immediately - even though the S.E.C. has 60-days to provide "comments" requiring the issuer's response.

2). P&A FUNDS SECURED AGAINST VIDEO / V.O.D. - HHSE has been working with a proven P&A funder for a structure which provides substantial (multi-million dollar) traunches of theatrical release support for qualifying titles under a major studio Video / V.O.D. assignment. HHSE will enjoy the benefits (and upfront fees) from the marketing of titles under this P&A structure - as well as earned sales fees from theatrical settlements. Furthermore, the assignment of video rights to the major studio partner relieves HHSE of the need for substantial video staff and manufacturing funds.

3). CO-PRODUCTION PARTNERS, INTERNATIONAL PRE-SALES, INCENTIVES AND "GAP" - With respect to the facilitation of a major feature film - such as "MELTDOWN" - the assembly of financing for this $10-mm production in many ways is easier than raising $500,000 for a small indie production. Why? Well, first of all, having three major stars in "MELTDOWN" provides pre-sale interest for the receipt of bankable licensing agreements. Next, the higher stature also encourages greater support from State Incentive programs, and finally the existence of significant pre-sales can be leveraged to obtain what is known as "Gap" financing in the entertainment industry (e.g., a bank loan for "the gap still needed" - secured against the unsold territories). We also may bring in "co-production partners" for a portion of financing or in-kind services, as a variation on the pre-sale model.

For Major feature films structured in this manner - in which HHSE has essentially "packaged" the financing elements and performed the Executive Producer or Studio function - there will be significant fees paid to HHSE upfront... as well as certain assignable allocated overhead expenses. Additionally, after completion of the production, HHSE will launch the films to theatres under the P&A structure described above - also generating operating overhead through marketing fees, booking services and sales settlements.


4). S-1 REGISTRATION - HHSE has been in discussions with three significant parties that have expressed support of buying HHSE shares under a S-1 Shelf Registration (simultaneous with the Form 10, or almost immediately thereafter). As presently envisioned, the S-1 would be launched in January with a total potential sale of up to 90-mm HHSE shares made available, with a base price anticipated in the $.045 range, and going all the way up to $.10 for the final traunch of shares. HHSE anticipates raising about $4.5-mm in direct operating capital - while only diluting the total A/S by 10% or less. These direct funds will provide marketing support for MyFlix - as well as cash-flow flexibility for assisting with the development of the tent-pole Major Films and other ongoing operations. The anticipated buyers of the S-1 offering are long-term, strategic partners, and are not expected to sell any of their shares in the first year or two. The structure of the S-1 incentivizes earlier subscribers, as the price per share increases as the inventory of S-1 shares is diminished. The base price of the first traunch of S-1 shares is being established to be at a level estimated to start at 150% of the VWAP of the HHSE shares - which means that these new shareholders are buying equity at a significant premium "above" market. The S-1 Registration will be filed shortly after the Form 10, as the company will await any initial feedback and comments to the registration statement.

As stated above - the more specific details for each of these major activities for HHSE requires more than a summary blog. But the information above provides a good outline of where we are, and where we are going.

Yes, it's GREAT that a movie like "GETTING GRACE" is listed as a BEST SELLER for Walmart.com... who knows? Maybe it will hold its shelf placements through Black Friday (as per the HHSE marketing plan), and ultimately deliver a wonderful Q4 for HHSE? But long-term, it's the expectation that FOUR "Major Films" could deliver $100-mm in revenues... as can MYFLIX... that is the driving force for this well-planned reinvention of the company's operating model!

STAY TUNED!






The GETTING GRACE international sales activities launched this week at the AMERICAN FILM MARKET in Santa Monica, CA. To better conform to international packaging tastes, a different key art campaign was developed.


http://hannoverhousemovies.blogspot.com/2018/...vents.html






Myflix-Image.jpg








HHSE

Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Core Lab's Quarterly Grit: Navigating a Turbulent Market

Updated Category News Views 71

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Continue Reading
Infoya Surges with 665% Growth, Wins Fast 50 Spot

Updated Category News Views 102

From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...

Continue Reading
White House Photographer Reveals Unseen Historic Moments

Updated Category News Views 94

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Continue Reading
Doximity Faces Legal Heat: 23% Stock Plunge Analyzed

Updated Category News Views 12

Doximity's Rollercoaster: Steep Drop Amid Lawsuits Imagine watching your portfolio take a gut-wrenching plunge—and that's the rollercoaster ride Doximity investors experienced. On May 14, 2026, Doximity's stock nosedived by 23%, closing at $18.01 per share. This tumble, which marked a painful conclusion to a series of financial disappointments, has thrown the company...

Continue Reading
Xyte's Record Quarter: Surging Demand & New CEO

Updated Category News Views 0

Setting New Records in the AV Industry There's buzz in the air over in Hoboken, New Jersey. Xyte, the AI cloud maestro you're starting to hear about more and more, has just smashed its own records this past September. It's not just a flash in the pan, either—this isn't the first time they've knocked it out of the park. Thanks to burgeoning enterprise demand and a...

Continue Reading
Royce Micro-Cap Trust: Navigating Small-Cap Waves

Updated Category News Views 42

Folks, if there's ever been a niche in this labyrinth of stocks, it’s the micro-cap territory. Royce Micro-Cap Trust (NYSE: RMT) is hefting the torch for smaller companies up to a billion in market cap. But is it leading the charge or getting steamrolled by market bear crawls? Understanding the Numbers Time to get dirty with some numbers, because for Royce Micro-Cap...

Continue Reading
McKinsey and Parloa Join Forces on AI Customer Service

Updated Category News Views 66

AI-Revolutionizing Customer Service: The New Partnership Out of the boardroom and into the trenches, McKinsey joins hands with Parloa, aiming to reshape how enterprises handle customer service through artificial intelligence. Forget all the corporate fluff you've heard before; these guys are dead set on closing the massive gap companies face in deploying AI agents...

Continue Reading
BlueNord Signals Strategic Shift with Vår Energi Merger

Updated Category News Views 47

BlueNord's Bold Move in the Energy Sector With the ink barely dry on their third-quarter results, BlueNord has dropped a bombshell: a merger approved with Vår Energi. This isn't just another page in their corporate books—it's a strategic pivot that could redefine their place within the oil and gas arena. Anybody keeping an eye on the energy sector right now should sit...

Continue Reading
BetaNXT and Pave Finance Transform Wealth Management

Updated Category News Views 52

AI Takes Center Stage in Wealth Management You know, it's not every day we see two powerhouses like BetaNXT and Pave Finance buddying up to shake up the financial advisory world. This partnership's all about harnessing AI to give wealth management firms and financial advisors some serious firepower in portfolio planning. BetaNXT, already a big name with its slick...

Continue Reading
Storyteq's AI Edge Earns Gartner Leader Status Again

Updated Category News Views 69

Pioneering AI in Digital Asset Management Alright, folks, this ain't just another tech release to gloss over with your morning coffee—ITG's Storyteq has snagged the 'Leader' title in Gartner's Magic Quadrant for Digital Asset Management. It's no small feat to earn such recognition three years running, and the secret sauce is their advanced AI capabilities. A Unified AI...

Continue Reading

Top 5 Most Recently Viewed Articles

Rgenta Therapeutics Presents Innovative Data on RGT-61159

Updated Category News Views 192

Rgenta Therapeutics Unveils Preclinical Data on RGT-61159 WOBURN, Mass. – Rgenta Therapeutics, a pioneering biotechnology firm focused on the development of small molecule drugs targeting RNA for cancer and neurological disorders, has made an exciting announcement regarding its lead program, RGT-61159. This promising small molecule inhibitor, which selectively targets...

Continue Reading
TriMas Packaging Showcases Innovations at Upcoming Trade Events

Updated Category News Views 122

TriMas Packaging's Participation in Major Trade Shows TriMas Packaging, a leading group under TriMas (NASDAQ: TRS), is thrilled to announce its involvement in two prominent trade exhibitions. At these events, the company will display its extensive range of innovative and eco-friendly dispensing and closure product solutions that have garnered attention in the industry....

Continue Reading
Understanding Apollo Global Management's Recent Market Trends

Updated Category News Views 109

Understanding Apollo Global Management's Recent Market Trends The market is currently witnessing a notable shift in investor sentiment towards Apollo Global Management (NYSE: APO). This trend is not only striking but worth examining closely for anyone interested in market movements. Recent tracking of options activity has highlighted an interesting wave of bullish...

Continue Reading
Capricor Faces Securities Fraud Lawsuit: Investor Action Key

Updated Category News Views 16

Investors Take the Stage in Capricor Securities Case Here's something that'll make any shareholder's pulse quicken: Capricor Therapeutics, Inc. (NASDAQ: CAPR) is caught in a whirlwind of legal drama, and it's no soap opera. Rather, it's a class action lawsuit, brought forth by the vigilant folks over at Schall, Brown & Schwartz LLP ('SBS'), aimed squarely at alleged...

Continue Reading
Broad Arrow Auctions Collects $14.5 Million in Sales Triumph

Updated Category News Views 333

Broad Arrow Auctions Kicks Off a Successful Year Broad Arrow Auctions, an esteemed arm of Hagerty, recently embarked on its 2025 auction calendar with a remarkable showcase—the Academy of Art University Collection Auction. Held at the university's museum facilities, this auction captured the attention of classic car enthusiasts and collectors alike. A Glance at the...

Continue Reading